New £800-a-dose jab offers hope for diabetics suffering macular oedema - Daily Mail

Brolucizumab treats fluid build-up in the eyes - called diabetic macular oedema - that can lead to blurred vision and, eventually, loss of sight.

A drug that can save diabetics from going blind is now being offered on the NHS. Brolucizumab treats fluid build-up in the eyes called diabetic macular oedema that can lead to blurred vision and, eve… [+4146 chars]

full article...